Indeed, the subsequent luciferase reporter and CHIP assay confirmed the binding site of HIF-1α of the HK2 promoter, which further demonstrated the underlying mechanism by which LARS positively regulated DLBCL progression. Here, LARS1 is linked to diffuse large B-cell lymphoma.